NCT06455241 Feasibility and Efficacy of HABIT for Enhancing Daily Hand-Use Post Stroke
| NCT ID | NCT06455241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tel Aviv University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-06-02 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-06-02 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This experimental design will assess the feasibility \& initial effectiveness of HABIT - a novel occupational therapy to increase the daily hand-use of the affected upper extremity post stroke. Assessments will be conducted at four time points: baseline, pre, post the HABIT intervention and follow-up (by phone) .
Eligibility Criteria
Inclusion Criteria: * Adults aged 18 and above residing in their own homes * Hebrew speakers * Up to 10 years post-stroke * Mild upper extremity motor impairment but still report difficulty using their hand. This will be determined by a total score of 43/66, including the Hand subtest score of 7/14 points of the Fugl-Meyer Motor Assessment. * No significant cognitive decline (score of 19 and above on Montreal Cognitive Assessment) * Able to walk with or without assistive devices * Able to provide informed consent by signing a consent form * Full function of both hands and independent in daily function prior to stroke Exclusion Criteria: * Other neurological conditions or psychiatrists * with moderate or significant proprioception deficit (Thumb Localization Test \>1)
Contact & Investigator
Debbie Rand
PRINCIPAL INVESTIGATOR
Tel Aviv University
Frequently Asked Questions
Who can join the NCT06455241 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06455241 currently recruiting?
Yes, NCT06455241 is actively recruiting participants. Contact the research team at drand@tauex.tau.ac.il for enrollment information.
Where is the NCT06455241 trial being conducted?
This trial is being conducted at Tel Aviv, Israel.
Who is sponsoring the NCT06455241 clinical trial?
NCT06455241 is sponsored by Tel Aviv University. The principal investigator is Debbie Rand at Tel Aviv University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.